Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOPMAIE, K; OKOSHI, Y; TAKAIWA, N et al.Annals of oncology. 2014, Vol 25, Num 1, pp 298-299, issn 0923-7534, 2 p.Article

Adaptive Prediction Model in Prospective Molecular Signature-Based Clinical StudiesGUANGHUA XIAO; SHUANGGE MA; MINNA, John et al.Clinical cancer research (Print). 2014, Vol 20, Num 3, pp 531-539, issn 1078-0432, 9 p.Article

Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor EffectsJI YOUNG YOO; HURWITZ, Brian S; CRIPE, Timothy P et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3787-3798, issn 1078-0432, 12 p.Article

Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic TargetsTAO YANG; RYCAJ, Kiera; LIU, Zhong-Min et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 11, pp 2922-2927, issn 0008-5472, 6 p.Article

Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal modelVIEIRA COSTA, Marcelo Leite; PEREIRA LIMA, Roberto César; PONTES DE SOUZA, Marcellus Henrique Loiola et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 711-720, issn 0344-5704, 10 p.Article

Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjectsDONGYANG LIU; JI JIANG; LI ZHANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 721-727, issn 0344-5704, 7 p.Article

Complex Disease-, Gene-, and Drug-Drug Interactions: Impacts of Renal Function, CYP2D6 Phenotype, and OCT2 Activity on Veliparib PharmacokineticsJING LI; SEONGHO KIM; XIANYI SHA et al.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 3931-3944, issn 1078-0432, 14 p.Article

Cotargeting the PI3K and RAS Pathways for the Treatment of Neuroendocrine TumorsVALENTINO, Joseph D; JING LI; JUN SONG et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1212-1222, issn 1078-0432, 11 p.Article

Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotideRODRIGUEZA, Wendi V; WOOLLISCROFT, Michael J; BISGAIER, Charles L et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 151-166, issn 0344-5704, 16 p.Article

Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic CavityOKOYE, Christian C; JABLONS, David M; JAHAN, Thierry M et al.American journal of clinical oncology. 2014, Vol 37, Num 4, pp 350-355, issn 0277-3732, 6 p.Article

Effects of the combination of TRC105 and bevacizumab on endothelial cell biologyYINGMIAO LIU; HONGYU TIAN; BLOBE, Gerard C et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 851-859, issn 0167-6997, 9 p.Article

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal studyHESKETH, P. J; ROSSI, G; RIZZI, G et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1340-1346, issn 0923-7534, 7 p.Article

Frequent Overexpression of HMGA2 in Human Atypical Teratoid/Rhabdoid Tumor and Its Correlation with let-7a3/let-7b miRNAKEQIANG ZHANG; HANLIN GAO; PEIGUO CHU et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1179-1189, issn 1078-0432, 11 p.Article

High-dose vitamin B1 reduces proliferation in cancer cell lines analogous to dichloroacetateHANBERRY, Bradley S; BERGER, Ryan; ZASTRE, Jason A et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 3, pp 585-594, issn 0344-5704, 10 p.Article

How can communication by oncologists enhance patients' trust? An experimental studyHILLEN, M. A; DE HAES, H. C. J. M; STALPERS, L. J. A et al.Annals of oncology. 2014, Vol 25, Num 4, pp 896-901, issn 0923-7534, 6 p.Article

Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucosePHILIPS, Katherine B; KURTOGLU, Metin; LEUNG, Howard J et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 349-361, issn 0344-5704, 13 p.Article

Molecular Pathways: Targeting Resistance in the Androgen Receptor for Therapeutic BenefitMOSTAGHEL, Elahe A; PLYMATE, Stephen R; MONTGOMERY, Bruce et al.Clinical cancer research (Print). 2014, Vol 20, Num 4, pp 791-798, issn 1078-0432, 8 p.Article

Natural Killer Cells: The Secret Weapon in Dendritic Cell Vaccination StrategiesVAN ELSSEN, Catharina H. M. J; OTH, Tammy; GERMERAAD, Wilfred T. V et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1095-1103, issn 1078-0432, 9 p.Article

Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidineTHOTTASSERY, Jaideep V; SAMBANDAM, Vijaya; ALLAN, Paula W et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 2, pp 291-302, issn 0344-5704, 12 p.Article

Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposureLEE, Suh-Young; KANG, Hye-Ryun; SONG, Woo-Jung et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 1021-1029, issn 0344-5704, 9 p.Article

Pharmacodynamic Biomarkers: Falling Short of the Mark?GAINOR, Justin F; LONGO, Dan L; CHABNER, Bruce A et al.Clinical cancer research (Print). 2014, Vol 20, Num 10, pp 2587-2594, issn 1078-0432, 8 p.Article

Pharmacokinetics of doxorubicin in pregnant womenRYU, Rachel J; EYAL, Sara; UMANS, Jason G et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 789-797, issn 0344-5704, 9 p.Article

Positron Emission Tomography Imaging with ¹⁸F-Labeled Z_HER2:2891 Affibody for Detection of HER2 Expression and Pharmacodynamic Response to HER2-Modulating TherapiesTROUSIL, Sebastian; HOPPMANN, Susan; NGUYEN, Quang-Dé et al.Clinical cancer research (Print). 2014, Vol 20, Num 6, pp 1632-1643, issn 1078-0432, 12 p.Article

Stressing the Development of Small Molecules Targeting HSP90NECKERS, Len; TREPEL, Jane B.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 275-277, issn 1078-0432, 3 p.Article

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic ActivityKENNEDY-NASSER, Alana A; KU, Stephanie; SAVOLDO, Barbara et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2215-2225, issn 1078-0432, 11 p.Article